COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE | Patent Publication Number 20220227819
US 20220227819 A1Publication DateJul 21, 2022
Original AssigneeThe University Of Chicago
Johnson & Johnson
Johnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsLena Thomer
Carla Emolo
Mark De Been
Jeroen Geurtsen
Olaf Schneewind
Dominique Missiakas
Molly McAdow
Carla Emolo
Mark De Been
Jeroen Geurtsen
Olaf Schneewind
Dominique Missiakas
Molly McAdow
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.